Literature DB >> 31740248

α-Haloacetophenone and analogues as potential antibacterial agents and nematicides.

Chongfen Yi1, Jixiang Chen1, Chengqian Wei1, Sikai Wu1, Shaobo Wang1, Deyu Hu1, Baoan Song2.   

Abstract

A series of α-haloacetophenones and analogues were synthesized. The bioassays show that some target compounds have good antibacterial activity against Xanthomonas oryzae pv. oryzae (Xoo), Xanthomonas axonopodis pv. citri (Xac) and Meloidogyne incognita (M. incognita). Especially, the compound 24 has good in vitro and in vivo antibacterial activities against Xoo, the EC50 value, curative and protection activities are 0.09 mg/L, 48.9%, and 52.3%, respectively, which are better than the thiodiazole copper and bismerthiazol. Meanwhile, the compound 24 has good in vitro antibacterial activity against Xac, and has an EC50 value of 1.6 mg/L. Moreover, the compound 19 exhibits good nematicidal activity M. incognita, with the LC50 value of 1.0 mg/L, which is better than the positive control avermectin. In addition, the compound 24 can inhibit the formation of extracellular polysaccharide and biofilm of Xoo, and change the permeability of cell membrane. α-haloacetophenone and analogues have the advantages of simple structure, high efficiency, broad spectrum of biological activity, and can be used as antibacterial agents and nematicides or lead compounds in the future.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial activity; Haloacetophenone; Nematocidal activity

Mesh:

Substances:

Year:  2019        PMID: 31740248     DOI: 10.1016/j.bmcl.2019.126814

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Design, synthesis, crystal structure, and in vitro antibacterial activities of sulfonamide derivatives bearing the 4-aminoquinazoline moiety.

Authors:  Suran Wan; Nan Wu; Ya Yan; Yehui Yang; Guangmin Tian; Lian An; Xiaoping Bao
Journal:  Mol Divers       Date:  2022-07-02       Impact factor: 2.943

2.  Discovery of Novel Dihydrolipoamide S-Succinyltransferase Inhibitors Based on Fragment Virtual Screening.

Authors:  Chengqian Wei; Junjie Huang; Yu Wang; Yifang Chen; Xin Luo; Shaobo Wang; Zengxue Wu; Jixiang Chen
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.